Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Antibiotic (Tobramycin) Delivered by Nebulized Sonic Aerosol for Chronic Rhinosinusitis Treatment of Cystic Fibrosis Patients: A Multicenter Double-blind Randomized Controlled Trial

NCT02888730 is registered in ClinicalTrials.gov with Virginie ESCABASSE as lead sponsor.

NCT NCT02888730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02888730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Antibiotic (Tobramycin) Delivered by Nebulized Sonic Aerosol for Chronic Rhinosinusitis Treatment of Cystic Fibrosis Patients: A Multicenter Double-blind Randomized Controlled Trial
Lead sponsor
Virginie ESCABASSE
Phase
Phase 3
Overall status
Terminated
Start date
February 16, 2017
Completion date
July 8, 2019
Enrollment
86 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis, lung diseases, rhinosinusitis